Kevin Taddei

Association between the presenilin-1 mutation Glu318Gly and complaints of memory impairment.

Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor.

Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants.

Two novel presenilin-1 mutations (Y256S and Q222H) are associated with early-onset Alzheimer's disease.

Increased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia.

A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease.

B-vitamins reduce plasma levels of beta amyloid.

Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease.

Distinct effects of testosterone on plasma and cerebrospinal fluid amyloid-beta levels.

Association of cardiovascular factors and Alzheimer's disease plasma amyloid-beta protein in subjective memory complainers.

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease.

The relationship between memory complaints, perceived quality of life and mental health in apolipoprotein Eepsilon4 carriers and non-carriers.

Olfactory dysfunction is associated with subjective memory complaints in community-dwelling elderly individuals.

Profiling brain and plasma lipids in human APOE epsilon2, epsilon3, and epsilon4 knock-in mice using electrospray ionization mass spectrometry.

Extensive proteomic screening identifies the obesity-related NYGGF4 protein as a novel LRP1-interactor, showing reduced expression in early Alzheimer's disease.

Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging.

APOE genotype results in differential effects on the peripheral clearance of amyloid-beta42 in APOE knock-in and knock-out mice.

Functional effects of genetic polymorphism in inflammatory genes in subjective memory complainers.

The dynamics of CD147 in Alzheimer's disease development and pathology.

Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian imaging, biomarkers and lifestyle (AIBL) study of ageing.

Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle study.

Direct exposure of guinea pig CNS to human luteinizing hormone increases cerebrospinal fluid and cerebral beta amyloid levels.

Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease.